Produção Nacional
Revisado por pares
Radioiodine therapy and age at menopause in patients with thyroid cancer
2005; Wiley; Volume: 64; Issue: 2 Linguagem: Inglês
10.1111/j.1365-2265.2005.02413.x
ISSN1365-2265
AutoresPedro Weslley Rosário, Tales Alvarenga Fagundes, Aranaí Villasboas Fagundes, Álvaro Luís Barroso, Leonardo Lamego Rezende, Eduardo L. Padrão, Valéria C. Guimarães, Saulo Purisch,
Tópico(s)Thyroid Cancer Diagnosis and Treatment
ResumoClinical EndocrinologyVolume 64, Issue 2 p. 225-226 Radioiodine therapy and age at menopause in patients with thyroid cancer Pedro Weslley Souza Rosário, Pedro Weslley Souza Rosário Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorTales Alvarenga Fagundes, Tales Alvarenga Fagundes Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorAranaí Villasboas Fagundes, Aranaí Villasboas Fagundes Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorÁlvaro Luís Barroso, Álvaro Luís Barroso Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorLeonardo Lamego Rezende, Leonardo Lamego Rezende Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorEduardo Lanza Padrão, Eduardo Lanza Padrão Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorValéria C. Guimarães, Valéria C. Guimarães Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorSaulo Purisch, Saulo Purisch Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this author Pedro Weslley Souza Rosário, Pedro Weslley Souza Rosário Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorTales Alvarenga Fagundes, Tales Alvarenga Fagundes Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorAranaí Villasboas Fagundes, Aranaí Villasboas Fagundes Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorÁlvaro Luís Barroso, Álvaro Luís Barroso Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorLeonardo Lamego Rezende, Leonardo Lamego Rezende Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorEduardo Lanza Padrão, Eduardo Lanza Padrão Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorValéria C. Guimarães, Valéria C. Guimarães Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this authorSaulo Purisch, Saulo Purisch Nuclear Medicine and Endocrinology Service, Santa Casa de Belo Horizonte, Minas Gerais, BrazilSearch for more papers by this author First published: 08 December 2005 https://doi.org/10.1111/j.1365-2265.2005.02413.xCitations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Vini, L., Hyer, S., Al-Saadi, A., Pratt, B. & Harmer, C. (2002) Prognostic for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgraduate Medical Journal, 78, 92–93. 2 Raymond, J.P., Izembart, M., Marliac, V., Dagousset, F., Merceron, R.E., Vulpillat, M. & Vallee, G. (1989) Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. Journal of Clinical Endocrinology and Metabolism, 69, 186–190. 3 Rosario, P.W., Fagundes, T.A., Fagundes, A.S., Barroso, A.L., Rezende, L.L., Padrao, E.L., Guimaraes, V.C., Horta, A.C., Franco, M. & Purisch, S. (2005) Ovarian function after radioiodine therapy in patients with thyroid cancer. Experimental Clinical Endocrinology and Diabetes, 113, 331–333. 4 Ceccarelli, C., Bencivelli, W., Morciano, D., Pinchera, A. & Pacini, F. (2001) 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. Journal of Clinical Endocrinology and Metabolism, 86, 3512–3515. 5 Alper, M.M. & Garner, P.R. (1985) Ovarian failure: its relationship to autoimmune disease. Obstetrics and Gynecology, 66, 27–30. 6 McKinley, S., Brambilla, D.J. & Posner, J.C. (1992) The normal menopause transition. Maturitas, 14, 103–115. Citing Literature Volume64, Issue2February 2006Pages 225-226 ReferencesRelatedInformation
Referência(s)